Panthenol Quintesence (Dexpanthenol)

After oral intake, Dexpanthenol is converted to pantothenic acid, which becomes part of coenzyme A. Coenzyme A is essential for fatty‑acid synthesis, energy production, and the formation of skin and hair proteins, thereby supporting cellular repair and normal metabolic processes.

The dosage of Panthenol Quintesence is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and response to therapy. Patients should follow the specific instructions provided by their healthcare professional.

Pregnant or breastfeeding individuals should discuss use with their healthcare provider. While Dexpanthenol is a vitamin derivative, safety has not been definitively established for these populations, and a professional assessment is required before starting therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Panthenol Quintesence delivers Dexpanthenol, which is directly converted to pantothenic acid in the body, offering a rapid source of vitamin B5. Compared with standard pantothenic acid salts, Dexpanthenol may provide enhanced bioavailability and is often preferred for oral supplementation in deficiency states.

Store the product at ambient temperature, ideally below 25 °C. Keep it in the original packaging to protect from moisture and direct sunlight. Do not expose the tablets or oral formulation to excessive heat or humidity, which could affect stability.

Panthenol Quintesence is taken orally, usually with water. The exact administration schedule, such as timing relative to meals, should follow the prescribing clinician’s directions to ensure optimal absorption and therapeutic effect.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, widespread rash, or jaundice.

Individuals with a known hypersensitivity to Dexpanthenol or any excipients in the formulation should avoid the product. Additionally, patients with severe renal impairment or those taking medications that may interact significantly should consult a healthcare professional before use.